Stocks

Why Vermilion Energy Inc. stock is sliding today

By Wealth Awesome Newsroom -
Stocks & ETFs:VET.TO

Get VET alerts:

Photos provided by Pexels

Vermilion Energy Inc. is experiencing a significant drop in its stock price, which reflects investor concerns about its recent strategic decisions.

In the latest trading session, Vermilion Energy Inc. (VET.TO) saw its stock price fall by 2.83%, closing at CA$12.89. This decline comes as the company undergoes a series of asset sales and strategic repositioning efforts, raising questions among investors about its long-term growth potential.

Investor takeaway: Investors should keep a close eye on Vermilion's ongoing asset sales and financial health as the company works to stabilize its balance sheet amid market pressures.

Advertisement

Qtrade Direct Investing

Get up to $2,000 cash back

Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.

Vermilion Energy Inc.

VET.TO

Full stock page โ†’

VET.TO

Vermilion Energy Inc.

Source:WealthAwesomeWealthAwesome
โ†‘ $2.37 (18.01%)
120 day period
$12.43$16.13$19.83Jan 30Apr 28Jul 22

Market cap

$2.10B

Div. yield

3.83%

Div. / share

$0.53

52W high

$20.13

52W low

$9.34

1W change

+13.03%

Beta

0.49

Analyst Price Targets

Based on analyst covering VET

๐Ÿ“ˆ

Wall Street analysts forecast VET stock price to rise 30.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$20.18

+30.0% Upside

Current Price

C$15.53

Last close

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on VET's historical volatility

HistoricalForecast68%95%
C$7.47C$10.74C$14.01C$17.29C$20.56C$23.84TodayMar 16May 20Jul 22Sep 3Oct 17Nov 29

30-Day Vol

46.0%

Annualized

90-Day Vol

59.8%

Annualized

Trend (90d)

-42.4%

Annualized drift

90d Mean

C$13.35

Expected price

HorizonExpected68% Range (1ฯƒ)
30 trading daysC$14.77C$12.60 โ€“ C$17.31
60 trading daysC$14.04C$11.21 โ€“ C$17.57
90 trading daysC$13.35C$10.14 โ€“ C$17.57

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯƒ, 95% band = ยฑ2ฯƒ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

CA$12.89

Vermilion's stock has dropped to CA$12.89, indicating a significant loss of market confidence during this period of strategic change.

Bull case

Vermilion's recent asset sales, including its U.S. assets and Saskatchewan properties, could ultimately strengthen its financial position by reducing debt. This might lead to a more sustainable business model in the long run.

Bear case

The stock's decline may signal investor skepticism about Vermilion's ability to effectively manage its portfolio and generate consistent profits, especially given its negative profit margin of -46.65%.

Recent Performance Overview

Vermilion Energy's stock has been on a downward trend, closing at CA$12.89 after a 2.83% drop in the last trading session. This decline raises concerns about the company's financial stability as it undertakes significant asset sales to reduce debt.

Strategic Moves and Market Reaction

The recent sale of Vermilion's U.S. assets for $120 million and its Saskatchewan properties for $415 million is part of a broader strategy to streamline operations and manage debt. However, these moves have not yet reassured investors, as seen in the stock's performance. The market is closely watching to see if these strategies will lead to improved financial health.

Looking Ahead

As Vermilion Energy continues to navigate its strategic repositioning, investors should stay alert. The company's ability to manage its debt and improve profitability will be crucial in determining its stock performance in the coming months. For further insights, check out our detailed analysis on VET.TO.

Advertisement

Sponsored links

Advertisement